Current:Home > reviewsCancer drug shortages could put chemo patient treatment at risk -InvestTomorrow
Cancer drug shortages could put chemo patient treatment at risk
View
Date:2025-04-24 00:12:02
Chattanooga, Tennessee — Carol Noon has an aggressive form of endometrial cancer. It's treatable, but there is no time to waste.
Due to a drug shortage, she told CBS News "there's no guarantee" that the life-saving chemotherapy drugs she needs will be available throughout the course of her treatment.
The night before her second dose of chemotherapy, the 61-year-old Noon received a call from her doctor to inform her that the hospital had run out of her treatment. Thankfully, Noon got her dose a week later.
"I think it's an emotional rollercoaster," Noon said. "It's very frustrating to know that there's a standard of care, these two generic drugs, and I can't get them."
She said her doctors are "frustrated. "We're not sure what the next steps are. And we're just hoping there's gonna be treatment available."
Patients like Noon are given carboplatin and cisplatin, generic medications that aren't profitable for manufacturers to produce — and few are made in the U.S.
Since the start of the COVID-19 pandemic, the international supply chain for cancer medications has been strained and the situation has become dire. Food and Drug Administration inspectors found "widespread problems" at a factory in India that makes more than half of the U.S. supply of cisplatin.
In March, the FDA reported that Pluvicto — a drug used to treat advanced prostate cancer — is in short supply. Pluvicto is only manufactured in Italy.
And the issue isn't just limited to cancer drugs. A report also released in March by the Senate Homeland Security Committee found that 295 drugs were in short supply in the U.S. last year, marking a five-year high.
"We had to make some decisions about who we were going to prioritize during this difficult time," said oncologist Dr. Kari Wisinski with the University of Wisconsin Health, who told CBS News she had never seen a shortage this serious.
"The question is, could people die because of this shortage?" Wisinksi asked. "I think it all depends on how long it occurred. If we experienced a prolonged shortage of chemotherapy, then yes, I do think people could die."
In response, the FDA last month temporarily began importing cisplatin from a Chinese drug manufacturer Qilu Pharmaceutical, which is not FDA approved.
"Someday, I'm gonna die," Noon said. "I really would rather not die because these standard generic drugs weren't available to me. And I can't imagine being in that position and questioning what happened, my family having that doubt and my friends having that doubt. Was it the cancer, or was it that there was not enough chemotherapy and it got rationed."
- In:
- Food and Drug Administration
- Cancer
Norah O'Donnell is the anchor and managing editor of the "CBS Evening News." She also contributes to "60 Minutes."
TwitterveryGood! (423)
Related
- Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
- Dad who said “If I can’t have them neither can you’ pleads guilty to killing 3 kids
- Teen plotted with another person to shoot up, burn down Ohio synagogue, sheriff says
- Michigan State reaches settlements with families of students slain in mass shooting
- US wholesale inflation accelerated in November in sign that some price pressures remain elevated
- California men charged with running drugs to Australia, New Zealand disguised as car parts, noodles
- US homelessness up 12% to highest reported level as rents soar and coronavirus pandemic aid lapses
- Hague court rejects bid to ban transfer to Israel of F-35 fighter jet parts from Dutch warehouse
- A South Texas lawmaker’s 15
- Court denies review of Pac-12 appeal, handing league control to Oregon State, Washington State
Ranking
- Man can't find second winning lottery ticket, sues over $394 million jackpot, lawsuit says
- Federal Reserve on cusp of what some thought impossible: Defeating inflation without steep recession
- Tipping fatigue exists, but come on, it’s the holidays: Here’s how much to tip, more to know
- Dog respiratory illness cases confirmed in Nevada, Pennsylvania. See map of impacted states.
- Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
- A man and daughter fishing on Lake Michigan thought their sonar detected an octopus. It turned out it was likely an 1871 shipwreck.
- UNC-Chapel Hill names former state budget director as interim chancellor
- No room at the inn? As holidays approach, migrants face eviction from New York City shelters
Recommendation
Arkansas State Police probe death of woman found after officer
Police officer fatally shoots 19-year-old in Mesquite, Texas, suspect in a vehicle theft
What econ says in the shadows
Queen Camilla is making her podcast debut: What to know
Bill Belichick's salary at North Carolina: School releases football coach's contract details
Indianapolis police chief to step down at year’s end for another role in the department
Shawn Johnson East Shares First Photos of Baby No. 3 and Hints at Baby Name
Federal agents seize illegal e-cigarettes worth $18 million at LAX